期刊文献+

复方丹参注射液预防肝静脉闭塞症58例报告 被引量:11

THE REPORT OF 58 CASES TO PREVENT HEPATIC VENO-OCCLUSIVE DISEASE WITH COMPOUND DANSHEN FOR INJECTION
原文传递
导出
摘要 目的 :探讨预防造血干细胞移植 (HSCT)后肝静脉闭塞症 (HVOD)的有效方法。方法 :对患者从预处理开始的体重、腹痛并肝大、腹水、总胆红素、谷草转氨酶 (AST)、谷丙转氨酶(AL T)、血浆凝血酶原时间 (PT)、活化部分凝血活酶时间 (APTT)等指标进行动态观察并分析结果。结果 :无一例发生 HVOD。结论 :复方丹参注射液可以有效地预防 HVOD的发生。 Objective:To investigate the effectual ways of preventing hepatic veno occlusive disease (HVOD) after hematological stem cell transplantation (HSCT).Methods:To observe weight, abdominal pain and hepatomegalia, hydroperitoneum, total bilirubin, aspartate amintransferase (AST), alanine amintransferase (ALT), prothrombin time (PT), activated partial thromboplastin (APTT) from the beginning of preparative regimen of patients, and analysis these results.Results:No one developed HVOD.Conclusion:Compound Dansen for injection effectually prevents HVOD.
机构地区 河南省肿瘤医院
出处 《白血病.淋巴瘤》 CAS 2003年第3期146-147,共2页 Journal of Leukemia & Lymphoma
关键词 复方丹参注射液 肝静脉闭塞症 造血干细胞移植 Compound Dansen for injection Hepatic veno occlusive disease Hematological Stem Cell Transplantation
  • 相关文献

参考文献9

  • 1曹履先.临床骨髓移植[M].北京,军事医学科学出版社,1997.61.
  • 2沈志样 欧阳仁荣.血液肿瘤学[M].北京:人民卫生出版社,1999.165.
  • 3曹履先.临床骨髓移植[M].北京:军事医学科学出版社,1997.61.
  • 4Shulman H M. Hepatic veno-occlusive disease liver toxicity syndrome after bone marrow transplantion[J]. Bone Marrow Transplant, 1992, 10: 197.
  • 5McDonald G B. The clinical course of 53 patients with venoocclusive disease of liver after bone marrow transplantion[J].Transplant, 1985, 39:603.
  • 6Baglin T P. Veno-occlusive disease of liver complication bone marrow transplantion [J]. Bone Marrow Transplant, 1996,13: 1.
  • 7McDonald G B. Veno-occlusive disease of liver and multiorgan failure after bone marrow transplantion, a cohort study of 355 patients[J]. Ann Inter Med, 1993, 118, 255.
  • 8Rozman C. Risk factor for hepatic veno-ocelusive disease following HLA-identieal sibling bone marrow transplantion for leukemia[J]. Bone Marrow Transvlant, 1996. 17: 75.
  • 9Schegel P G. Hepatic veno-occlusive disease in pediatric stem cell recipients: successful treatment with continuos infusion of prostagalandin E1 and low dose heparin [J]. Ann Hematol,1998,76:37.

共引文献1

同被引文献162

引证文献11

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部